A Florida company that has seen an opportunity in the N95 mascara scandal when the coronavirus pandemic started has 30 million of them without selling it because there are no buyers in the United States.
DemeTech, a factory establishment in Miami, accuses China of bargaining prices, while hiring an open-ended mayor the problem is that stadium buyers are reminded of the new manufacturers.
All the principles of the past year, according to China, which produced the mascara that were sold in the world, were accused of being involved in the initial terror that produced the pandemic.
In April, some hospitals with covid-19 report patients had mascarillas for three days, following a survey by Premier, a company that buys medical supplies for 4,100 United States hospitals and health centers.
Google, Amazon en Facebook-verbod op entonces la promotion and sale in its N95 mascara sites, to avoid nervous users agotaran an insumo deurslaggewende for the medical staff.
Entonces DemeTech, which is not familiar with the manufacture of sutures, is also known for the production.
New months and tens of millions of dollars spent, DemeTech’s N95 respirators will receive the federal governor’s approval, but it does not have enough buyers.
Luis Arguello, vice president of the company, declares in the AFP that there is “an unfortunate disconnection between the manufacturers and the public that wants to buy the product”.
China renews social
Arguello adjudica esta “desconexión” a dos factors.
A primer lugar, afirma, the hospitals that buy in mayoreo prefieren are most affordable in China.
A set of 20 N95 tapes from DemeTech sold for a total of $ 75. Although the mayor does not think so, his price is higher than the Chinese mascarillas.
“We are considerably more carous because we use prime materials and mano of open stadiums”, explains Arguello.
A report from the New York Times last week identified some dozen corporate firms that, like DemeTech, are fighting to sell their N95 mascaras to the governor’s promises – ahead of Donald Trump and Joe Biden’s news – to privilege national production.
In the second place, The local companies no pueden sell their mascarillas in detail because it is impossible for the online manufacturers, debited to companies like Google and Facebook banning advertisers.
“The Mayor of digital companies thinks that it has good reasons, because it wants to reserve the product for the hospital sector and for the medicines”, Dommelsteuel Arguello. “But we have an excess, we have many masks in our inventory. Here we have about 30 million”.
The N95 is considered the safest mascara to prevent coronavirus contagion because it filters 95% of the particles in the air.
Disconfianza
A year after the start of the pandemic, the N95 has made its initial debut with its “restricted” property, explained David Hargraves, vice president of Premier Suministros, the medical drug distribution company.
The demand is clearly high – the use of these mascarillas increased 500% since last July–, but also appeared new manufacturers and hospitals have existed for 150 days, on sale.
Geen hindernis, “tenemos que ser cuidadosos de ser demasiado optimistas”, gambling Hargraves. “Any change in the actual level of offer and demand could quickly compromise this market without hesitation and want to relocate in a difficult situation”.
For this reason, the N95 itself is a protected resource, which explains why the publicity ban is imposed on technology companies.
Premier makes sure to buy mascara like many local manufacturers – among them DemeTech– as extras.
But the hospitals, say the company, are the ones that have the ultimate buzzword in sales.
We have to approve the mascarillas inside our own inspection system, while others are reluctant to buy and dispose of waste products in many stages of pandemic surgery.
While this, Arguello says it is a “point of inflection”.
“We employ up to 3,000 new workers and continue to create and help the economy,” Doubles said, “we tend to lose 1,500 workers in mask production.”